Cranswick (CWK) Q1 2027 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2027 TU earnings summary
27 Jul, 2026Executive summary
Revenue for the 13 weeks to 27 June 2026 increased by 5.5% year-over-year, driven by strong volume growth of 8.2%.
Like-for-like revenue rose 4.0% with volumes up 6.4%, reflecting robust demand for core products and lower input prices passed to customers.
Growth was led by poultry, fresh pork, convenience, gourmet, and pet products, with notable retail and wholesale channel performance.
Continued investment in capacity and efficiency, including major expansions at Eye and Hull facilities.
Formed a joint venture with The Jolly Hog Group, expanding premium product offerings.
Financial highlights
Strong cash generation kept net debt at quarter-end in line with March 2026, despite ongoing capital investment.
Committed, unsecured facilities of £360 million provide significant financial headroom.
Market expectations for adjusted profit before tax for FY27 range from £230.0m to £243.0m, with an average of £234.3m.
Outlook and guidance
Outlook for the year ending 27 March 2027 remains in line with current market expectations.
Board confident in further development, supported by a diverse customer base, product breadth, and robust financial position.
Acknowledges potential risks from Middle East conflict and domestic political changes.
Latest events from Cranswick
- Strong revenue and margin growth, record investment, and robust outlook for expansion.CWK
H2 2026 - Record Christmas trading and strong Q3 growth drive profit outlook to upper market range.CWK
Q3 2026 TU - Double-digit revenue and profit growth, record investment, and strong outlook for the year.CWK
H1 2026 - Revenue up 9.7% year-over-year, with strong growth and positive outlook maintained.CWK
Q1 2026 TU - Adjusted profit before tax up 17.4% on strong volume growth and margin expansion.CWK
H1 2025 - Upgraded FY25 outlook driven by strong trading, volume growth, and ongoing investment.CWK
Trading Update - Q1 revenue up 6.7% with strong UK demand and continued investment in capacity.CWK
Q1 2025 TU - Record revenue and margin growth, strong investment, and 35 years of dividend increases.CWK
H2 2025 - Record Q3 growth and JSR Genetics acquisition drive supply security and efficiency.CWK
Q3 2025 TU